Dougherty & Co began coverage on shares of Transcat, Inc. (NASDAQ:TRNS) in a research note released on Wednesday morning, MarketBeat.com reports. The firm issued a buy rating and a $20.00 price target on the scientific and technical instruments company’s stock.

Transcat (NASDAQ:TRNS) opened at 13.00 on Wednesday. The company has a market cap of $92.68 million, a price-to-earnings ratio of 20.63 and a beta of 0.34. The stock has a 50 day moving average price of $12.86 and a 200 day moving average price of $12.26. Transcat has a 52 week low of $10.00 and a 52 week high of $14.05.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 earnings per share (EPS) for the quarter. The firm had revenue of $36.28 million for the quarter. Transcat had a net margin of 3.03% and a return on equity of 10.37%. On average, equities analysts forecast that Transcat will post $0.64 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Transcat, Inc. (TRNS) Coverage Initiated by Analysts at Dougherty & Co” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://theolympiareport.com/2017/08/27/transcat-inc-trns-coverage-initiated-by-analysts-at-dougherty-co.html.

In other news, Director Paul D. Moore sold 4,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $13.00, for a total transaction of $52,000.00. Following the sale, the director now directly owns 57,698 shares in the company, valued at approximately $750,074. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Carl E. Sassano sold 7,500 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $13.02, for a total transaction of $97,650.00. Following the sale, the director now owns 79,075 shares in the company, valued at $1,029,556.50. The disclosure for this sale can be found here. Insiders have bought a total of 2,081 shares of company stock worth $24,924 over the last 90 days. Corporate insiders own 8.80% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Punch & Associates Investment Management Inc. boosted its stake in shares of Transcat by 16.8% in the second quarter. Punch & Associates Investment Management Inc. now owns 314,658 shares of the scientific and technical instruments company’s stock valued at $3,823,000 after buying an additional 45,308 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Transcat by 3.4% in the second quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after buying an additional 4,450 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Transcat by 9.5% in the second quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after buying an additional 1,570 shares in the last quarter. QCI Asset Management Inc. NY boosted its stake in shares of Transcat by 10.0% in the second quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock valued at $299,000 after buying an additional 2,226 shares in the last quarter. Finally, Neuberger Berman Group LLC boosted its stake in shares of Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after buying an additional 4,900 shares in the last quarter. Hedge funds and other institutional investors own 57.88% of the company’s stock.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.